These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 33854634)

  • 21. Detection of autoantibodies to a panel of tumor-associated antigens for the diagnosis values of gastric cardia adenocarcinoma.
    Zhou SL; Ku JW; Fan ZM; Yue WB; Du F; Zhou YF; Liu YL; Li Y; Tang S; Hu YL; Hu XP; Hou ZC; Liu J; Liu Y; Feng XS; Wang LD
    Dis Esophagus; 2015; 28(4):371-9. PubMed ID: 24612004
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improvement of protein immobilization for the elaboration of tumor-associated antigen microarrays: application to the sensitive and specific detection of tumor markers from breast cancer sera.
    Yang Z; Chevolot Y; Géhin T; Solassol J; Mange A; Souteyrand E; Laurenceau E
    Biosens Bioelectron; 2013 Feb; 40(1):385-92. PubMed ID: 23017679
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autoantibody Signatures as a Biomarker Panel for the Detection of Nasopharyngeal Carcinoma.
    Shi QP; Wang X; Liu ZX; Zhang JJ; Wang ZY
    Arch Med Res; 2021 Aug; 52(6):620-626. PubMed ID: 33653596
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating levels of autoantibodies against L1-cell adhesion molecule as a potential diagnostic biomarker in esophageal squamous cell carcinoma.
    Xu YW; Peng YH; Ran LQ; Zhai TT; Guo HP; Qiu SQ; Chen HL; Wu ZY; Li EM; Xie JJ
    Clin Transl Oncol; 2017 Jul; 19(7):898-906. PubMed ID: 28181176
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A panel of autoantibodies as potential early diagnostic serum biomarkers in patients with breast cancer.
    Liu Y; Liao Y; Xiang L; Jiang K; Li S; Huangfu M; Sun S
    Int J Clin Oncol; 2017 Apr; 22(2):291-296. PubMed ID: 27778118
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor-associated autoantibodies against Fascin as a novel diagnostic biomarker for esophageal squamous cell carcinoma.
    Chen WX; Hong XB; Hong CQ; Liu M; Li L; Huang LS; Xu LY; Xu YW; Peng YH; Li EM
    Clin Res Hepatol Gastroenterol; 2017 Jun; 41(3):327-332. PubMed ID: 27956255
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of serum autoantibodies against tumor-associated antigens as biomarkers in lung cancer.
    Li P; Shi JX; Xing MT; Dai LP; Li JT; Zhang JY
    Tumour Biol; 2017 Oct; 39(10):1010428317711662. PubMed ID: 29022480
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multipanel assay of 17 tumor-associated antibodies for serological detection of stage 0/I breast cancer.
    Sumazaki M; Ogata H; Nabeya Y; Kuwajima A; Hiwasa T; Shimada H
    Cancer Sci; 2021 May; 112(5):1955-1962. PubMed ID: 33605508
    [TBL] [Abstract][Full Text] [Related]  

  • 29. BMI-1 autoantibody as a new potential biomarker for cervical carcinoma.
    Tong YQ; Liu B; Zheng HY; He YJ; Gu J; Li F; Li Y
    PLoS One; 2011; 6(11):e27804. PubMed ID: 22132147
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Combination of IgA and IgG autoantibodies against Transcriptional Intermediary Factor-1γ contributes to the early diagnosis of Lung Cancer.
    Yu L; Lin X; Zhang L; Wu Q; Zhang S; Chen D; Pan X; Huang Y
    Int J Med Sci; 2020; 17(11):1561-1568. PubMed ID: 32669959
    [No Abstract]   [Full Text] [Related]  

  • 31. Identification of novel autoantibody signatures and evaluation of a panel of autoantibodies in breast cancer.
    Qiu C; Wang B; Wang P; Wang X; Ma Y; Dai L; Shi J; Wang K; Sun G; Ye H; Zhang J
    Cancer Sci; 2021 Aug; 112(8):3388-3400. PubMed ID: 34115421
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Luminex Approach to Develop an Anti-Tumor-Associated Antigen Autoantibody Panel for the Detection of Prostate Cancer in Racially/Ethnically Diverse Populations.
    Qiu C; Wang X; Batson SA; Wang B; Casiano CA; Francia G; Zhang JY
    Cancers (Basel); 2023 Aug; 15(16):. PubMed ID: 37627091
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor-infiltrating T cells correlate with NY-ESO-1-specific autoantibodies in ovarian cancer.
    Milne K; Barnes RO; Girardin A; Mawer MA; Nesslinger NJ; Ng A; Nielsen JS; Sahota R; Tran E; Webb JR; Wong MQ; Wick DA; Wray A; McMurtrie E; Köbel M; Kalloger SE; Gilks CB; Watson PH; Nelson BH
    PLoS One; 2008; 3(10):e3409. PubMed ID: 18923710
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Panel of SEREX-defined antigens for breast cancer autoantibodies profile detection.
    Kostianets O; Shyyan M; Antoniuk SV; Filonenko V; Kiyamova R
    Biomarkers; 2017 Mar; 22(2):149-156. PubMed ID: 27775439
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Performance of a multiplexed dual analyte immunoassay for the early detection of non-small cell lung cancer.
    Doseeva V; Colpitts T; Gao G; Woodcock J; Knezevic V
    J Transl Med; 2015 Feb; 13():55. PubMed ID: 25880432
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification and validation of new autoantibodies for the diagnosis of DCIS and node negative early-stage breast cancers.
    Lacombe J; Mangé A; Jarlier M; Bascoul-Mollevi C; Rouanet P; Lamy PJ; Maudelonde T; Solassol J
    Int J Cancer; 2013 Mar; 132(5):1105-13. PubMed ID: 22886747
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Case-Control Study: Smoking History Affects the Production of Tumor Antigen-Specific Antibodies NY-ESO-1 in Patients with Lung Cancer in Comparison with Cancer Disease-Free Group.
    Myšíková D; Adkins I; Hradilová N; Palata O; Šimonek J; Pozniak J; Kolařík J; Skallová-Fialová A; Špíšek R; Lischke R
    J Thorac Oncol; 2017 Feb; 12(2):249-257. PubMed ID: 27793776
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Using a panel of multiple tumor-associated antigens to enhance autoantibody detection for immunodiagnosis of gastric cancer.
    Wang S; Qin J; Ye H; Wang K; Shi J; Ma Y; Duan Y; Song C; Wang X; Dai L; Wang K; Wang P; Zhang J
    Oncoimmunology; 2018; 7(8):e1452582. PubMed ID: 30221047
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum Autoantibodies against STIP1 as a Potential Biomarker in the Diagnosis of Esophageal Squamous Cell Carcinoma.
    Xu YW; Liu CT; Huang XY; Huang LS; Luo YH; Hong CQ; Guo HP; Xu LY; Peng YH; Li EM
    Dis Markers; 2017; 2017():5384091. PubMed ID: 28852266
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Can serum autoantibodies be a potential early detection biomarker for breast cancer in women? A diagnostic test accuracy review and meta-analysis.
    Kathrikolly T; Nair SN; Mathew A; Saxena PPU; Nair S
    Syst Rev; 2022 Oct; 11(1):215. PubMed ID: 36210467
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.